APA aipamena

Gupta, R., Othman, T., Chen, C., Sandhu, J., Ouyang, C., & Fakih, M. (2019). Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer. Oncologist.

Chicago Style aipamena

Gupta, Rohan, Tamer Othman, Chen Chen, Jaideep Sandhu, Ching Ouyang, and Marwan Fakih. "Guardant360 Circulating Tumor DNA Assay Is Concordant With FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer." Oncologist 2019.

MLA aipamena

Gupta, Rohan, et al. "Guardant360 Circulating Tumor DNA Assay Is Concordant With FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer." Oncologist 2019.